Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume - Should You Buy?

Key Points

• Sysmex ADR trading volume surged 188% above its average daily volume, with 616,438 shares changing hands; the stock traded at $12.30 versus a prior close of $12.44.
• Zacks Research upgraded Sysmex from “Strong Sell” to “Hold,” while the two analysts covering the stock maintain a consensus “Hold” rating.
• Sysmex exceeded quarterly expectations, reporting $0.09 in EPS versus $0.07 forecast and revenue of $825.85 million versus $741.67 million expected. The company has a $7.48 billion market capitalization and FY 2026 guidance of $0.382 EPS.

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) saw unusually-high trading volume on Tuesday. 616,438 shares were traded during mid-day trading, an increase of 188% from the average daily volume of 213,742 shares. The stock last traded at $12.30 and had previously closed at $12.44.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Sysmex from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 18th. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, Sysmex has a consensus rating of "Hold".

Sysmex Price Performance

The stock has a market capitalization of $7.48 billion, a P/E ratio of 29.28 and a beta of 1.18. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40. The stock has a 50-day simple moving average of $11.92 and a 200 day simple moving average of $9.91.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its earnings results on Friday, August 7th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.02. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. The company had revenue of $825.85 million during the quarter, compared to the consensus estimate of $741.67 million. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. On average, equities analysts forecast that Sysmex Corporation ADR will post 0.41 earnings per share for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes clinical laboratory instruments, reagents and related information systems. Its products are used by hospitals, diagnostic laboratories and other healthcare providers to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology analyzers, which help laboratories evaluate blood cells and identify conditions such as anemia and leukemia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.